Balyasny Asset Management LLC Sutro Biopharma, Inc. Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $909,589 - $1.26 Million	214,021 New	214,021 $995,000
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $95,270 - $142,288	17,610 New	17,610 $142,000
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $1.04 Million - $1.37 Million	-61,432 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $1.11 Million - $1.46 Million	61,432 New	61,432 $1.14 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $105M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.